FDA lifts pregnancy-related warnings from lubiprostone label

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2013年 / 1433卷 / 1期
关键词：
D O I：
10.1007/s40278-013-0307-2
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3 / 3
相关论文
共 50 条
  • [1] New label revisions and warnings from the FDA
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2007, 107 (04) : 27 - 28
  • [2] The Penicillin Allergy Label and Pregnancy-Related Outcomes
    Ramsey, Allison
    Okrah, Kwame
    Mustafa, Shahzad
    Staicu, Mary
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB100 - AB100
  • [3] FDA lifts olestra warning label
    Walsh, K
    CHEMICAL WEEK, 2003, 165 (28) : 42 - 42
  • [4] FDA wants warnings on Enbrel label
    Reactions Weekly, 2008, 1208 (1) : 2 - 2
  • [5] Retrospective Application of the FDA Preliminary Pregnancy Safety Studies Framework to an Ongoing Pregnancy-Related Commitment
    Schroeder, Krista M.
    Grace, Elsie
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 481 - 481
  • [6] FDA WANTS LABEL WARNINGS ABOUT ANTIPARASITIC RESISTANCE
    不详
    JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2019, 254 (04): : 443 - 443
  • [7] Pregnancy-related Listeriosis
    Desai, Rahat Wadhwa
    Smith, Mary Alice
    BIRTH DEFECTS RESEARCH, 2017, 109 (05): : 324 - 335
  • [8] Pregnancy-related thromboembolism
    Vandenbroucke, JP
    Rosendaal, FR
    ANNALS OF INTERNAL MEDICINE, 1997, 127 (02) : 164 - 165
  • [9] Pregnancy-related claustrophobia
    Keane, Nessa
    Farrell, Amy
    Hallahan, Brian
    BMJ CASE REPORTS, 2022, 15 (01)
  • [10] Pregnancy-related mortality from preeclampsia and eclampsia
    MacKay, AP
    Berg, CJ
    Atrash, HK
    OBSTETRICS AND GYNECOLOGY, 2001, 97 (04): : 533 - 538
12345